Genetic Diversity and Immunological Responses in Plasmodium vivax Malaria

Plasmodium vivax exhibits remarkable genetic heterogeneity across its global range, driven by polymorphisms in surface antigens, repeat regions and invasion ligands. This diversity underpins variable patterns of transmission, relapse and drug sensitivity, complicating elimination efforts. Concurrently, host immune responses to P. vivax are shaped by allele‐specific antigenic variation: some variants elicit predominantly regulatory cytokine profiles that may mitigate pathology, whereas others provoke strong inflammatory cascades associated with higher parasite burdens and clinical complications. Naturally acquired antibodies against key merozoite proteins develop rapidly in endemic settings and correlate with reduced risk of high‐density infections, highlighting both protective mechanisms and challenges for vaccine design. Advances in molecular surveillance, population genetics and immunoepidemiology continue to elucidate how parasite diversity intersects with host immunity, informing tailored interventions, diagnostic tools and candidate vaccines for regions striving towards malaria elimination.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Genetic Diversity and Immunological Responses in Plasmodium vivax Malaria publication trend

The graph below shows the total number of articles in genetic diversity and immunological responses in plasmodium vivax malaria across all publications each year (not limited to Nature Index journals).

Technical terms

Multiplicity of infection (MOI): The number of genetically distinct parasite strains co-infecting a single host. Polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP): A genotyping technique that amplifies target DNA and uses restriction enzymes to reveal sequence variants via fragment size differences. Merozoite surface protein (MSP): Parasite antigens on the blood‐stage merozoite surface involved in red blood cell invasion, often highly polymorphic. Circumsporozoite protein (CSP): The dominant sporozoite surface antigen critical for liver stage invasion and a leading vaccine target, characterised by central repeat regions. Cytokine profile: The pattern and relative abundance of immune signalling molecules (for example IL-6, IL-10) that drive inflammatory or regulatory responses. Antigen polymorphism: The presence of multiple genetic variants of a given parasite protein that can alter immune recognition and vaccine efficacy.

References

1. Genetic diversity of Plasmodium vivax populations from the China–Myanmar border identified by genotyping merozoite surface protein markers. Tropical Medicine and Health (2023).
2. Advocating for PCR-RFLP as molecular tool within malaria programs in low endemic areas and low resource settings. PLOS Neglected Tropical Diseases (2023).
3. Polymorphisms in Plasmodium vivax Circumsporozoite Protein (CSP) Influence Parasite Burden and Cytokine Balance in a Pre-Amazon Endemic Area from Brazil. PLOS Neglected Tropical Diseases (2016).
4. Naturally Acquired Immune Responses to P. vivax Merozoite Surface Protein 3α and Merozoite Surface Protein 9 Are Associated with Reduced Risk of P. vivax Malaria in Young Papua New Guinean Children. PLOS Neglected Tropical Diseases (2013).